✦ LIBER ✦

3617 POSTER Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients With KRas Wild-Type Tumours in the United Kingdom

✍ Scribed by Samyshkin, Y.; Hertel, N.; Griebsch, I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN70 Cost-Effectiveness of Cetuximab an

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Economic analysis of bevacizumab, cetuxi

✍ Lawrence, Donna; Maschio, Michael; Leahy, Kevin J.; Yunger, Simon; Easaw, Jacob 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 466 KB

Cost-Effectiveness of Cetuximab, Cetuxim

✍ Hoyle, Martin; Peters, Jaime; Crathorne, Louise; Jones-Hughes, Tracey; Cooper, C 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

6079 Overall survival of patients with K

✍ Bokemeyer, C.; Bondarenko, I.; Hartmann, J.T.; DeBraud, F.; Schuch, G.; Zubel, A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PCN19 COST EFFECTIVENESS OF CETUXIMAB IN

✍ D Garrell; I Griebsch; Y Samyshkin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

✍ Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Jage 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 225 KB